Jin D J, Turnbough C L
Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
J Mol Biol. 1994 Feb 11;236(1):72-80. doi: 10.1006/jmbi.1994.1119.
One of the potential regulatory steps in procaryotic transcription is promoter clearance, a transition step in transcription initiation at which an RNA polymerase (RNAP) switches from the initial transcribing stage to the elongation stage. The biological significance of promoter clearance and the role of RNAP in this process are not understood. One approach to address these questions is to study mutant RNAPs that have altered promoter clearance. Because the antibiotic rifampicin inhibits transcription by preventing an initial transcribing complex from entering the elongation mode, mutant RNAPs which confer rifampicin (Rifr) are likely to be altered in promoter clearance. To test this hypothesis, we studied the effects of Rifr RNAPs on the pyrBI promoter, which is subject to control of promoter clearance in response to the availability of UTP. Two Rifr alleles that carry a different altered amino acid residue at position 529 of the beta subunit appeared to be defective in transcription from the pyrBI promoter in vivo. Biochemical analysis of one of these mutant RNAPs, RpoB3401 with a R529C change in the beta subunit, showed that it overproduces aborted initiation products from the pyrBI promoter and thus is defective in promoter clearance leading to reduced productive initiation. The severity of overproducing the aborted initiation products is an inverse function of the UTP concentration indicating that RpoB3401 has reduced affinity for UTP and thus is subject to a high Km barrier during promoter clearance. The defect of RpoB3401 in abortive initiation in vitro could account fully for its reduced initiation activity in vivo demonstrating the biological significance of abortive synthesis in transcription initiation. Our results indicate that at least part of the "rif region" is important for the process of abortive initiation and that promoter clearance can be regulated in part by modulating the Km of RNAP for nucleotides during initiation. The mutant enzyme is not altered in stuttering RNA synthesis at the pyrBI promoter, previously observed with wild-type RNAP. Our results also show that the mechanisms underlying the two non-productive initiation events (abortive synthesis and stuttering synthesis) at the pyrBI promoter are distinct.
原核转录中一个潜在的调控步骤是启动子清除,这是转录起始过程中的一个过渡步骤,在此过程中RNA聚合酶(RNAP)从初始转录阶段切换到延伸阶段。启动子清除的生物学意义以及RNAP在此过程中的作用尚不清楚。解决这些问题的一种方法是研究启动子清除发生改变的突变型RNAP。由于抗生素利福平通过阻止初始转录复合物进入延伸模式来抑制转录,赋予利福平抗性(Rifr)的突变型RNAP在启动子清除方面可能发生了改变。为了验证这一假设,我们研究了Rifr RNAP对pyrBI启动子的影响,该启动子会根据UTP的可用性受到启动子清除的调控。两个在β亚基第529位携带不同氨基酸残基改变的Rifr等位基因在体内似乎在pyrBI启动子的转录方面存在缺陷。对其中一种突变型RNAP(β亚基中R529C发生变化的RpoB3401)的生化分析表明,它从pyrBI启动子过量产生流产起始产物,因此在启动子清除方面存在缺陷,导致有效起始减少。过量产生流产起始产物的严重程度是UTP浓度的反函数,表明RpoB3401对UTP的亲和力降低,因此在启动子清除过程中受到高Km屏障的影响。RpoB3401在体外流产起始方面的缺陷可以完全解释其在体内起始活性的降低,这证明了流产合成在转录起始中的生物学意义。我们的结果表明,至少部分“利福平区域”对流产起始过程很重要,并且启动子清除可以部分通过在起始过程中调节RNAP对核苷酸的Km来调控。突变酶在pyrBI启动子处不会像之前在野生型RNAP中观察到的那样在RNA合成口吃方面发生改变。我们的结果还表明,pyrBI启动子处两种非生产性起始事件(流产合成和口吃合成)的潜在机制是不同的。